Article

A pivotal study on patients’ selection for BRCA1 and BRCA2 mutations by different models in Libyan breast cancer women

2023-01-20

Abstract excerpt

<h4>Introduction</h4> The BRCA mutation spectrum of familial breast cancer in Libya remains unknown. Several genetic models developed to predict the probability of BRCA1/2 mutations have not been applied in Libya, where the NCCN criteria are used for highly penetrating breast cancer susceptibility genes. This study aimed to predict BRCA1/2 mutation probability in familial breast cancer and eligibility for genetic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: baff85b7-a54b-5b2a-9037-9253a101c04a
DOI: 10.1101/2023.01.20.23284677

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A pivotal study on patients’ selection for BRCA1 and BRCA2 mutations by different models in Libyan breast cancer womenDOI 10.1101/2023.01.20.23284677Read

The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patients.Semantic proximity Read

Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.Semantic proximity Read

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan.Semantic proximity Read

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing SuggestionsSemantic proximity Read

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.Semantic proximity Read

A National Genomic Framework for Breast Cancer Risk Stratification in UAESemantic proximity Read

Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.Semantic proximity Read

BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review.Semantic proximity Read

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.Semantic proximity Read

Investigation on the clinicopathological characteristics and BRCA1/2 gene variation of patients in breast cancer pedigrees in Northern Henan ProvinceSemantic proximity Read

Hereditary Breast Cancer in Romania—Molecular Particularities and Genetic Counseling Challenges in an Eastern European CountrySemantic proximity Read

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.Semantic proximity Read